Stay updated on Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 in the page footer, indicating a newer page revision. This reflects an internal update rather than a substantive change to the page content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a newer release version of the page or its underlying system. This reflects a maintenance/version update rather than changes to visible content.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision tag at the bottom of the page updated from v3.6.2 to v3.6.3, reflecting a new version of the page.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer release. This reflects a minor update or bug fix rather than a change to study details or user-facing content.SummaryDifference0.1%

- Check63 days agoChange DetectedNew navigation items were added for How to Read a Study Record, Common Questions, and How to Join a Study, and the Intervention/Treatment label was introduced. The old Intervention / Treatment label and the prior revision note (v3.5.5) were removed.SummaryDifference0.5%

- Check70 days agoChange DetectedThe page's revision tag was updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a newer edition of the page was published.SummaryDifference0.1%

Stay in the know with updates to Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C Pancreatic Cancer Clinical Trial page.